TACE联合安罗替尼及信迪利单抗治疗CNLC Ⅱb~Ⅲb期肝癌患者的疗效及安全性评估
Evaluation of the efficacy and safety of TACE combined with anlotinib and sintilimab in the treatment of patient with CNLC stage ⅡB-ⅢB liver cancer
TACE联合安罗替尼及信迪利单抗治疗CNLC Ⅱb~Ⅲb期肝癌患者的疗效及安全性评估 |
| 童刚, 华杨, 彭薇, 赵桔, 胡钧文 |
|
Evaluation of the efficacy and safety of TACE combined with anlotinib and sintilimab in the treatment of patient with CNLC stage ⅡB-ⅢB liver cancer |
| TONG Gang, HUA Yang, PENG Wei, ZHAO Ju, HU Junwen |
| 图1 患者纳入和排除标准流程图 |
| Fig. 1 Flowchart of patient inclusion and exclusion criteria |
|
|